PDF(3867 KB)
Application of a deep-learning cascade model for near-infrared autofluorescence parathyroid identification
SHI Jin-yang, LIN Xuan, WANG Si-si, HUANG Wen-yu, HE Shao-feng, TANG Zi-han, LIN Meng-ting, CHEN Fei, ZHAO Wen-xin, WANG Bo
Chinese Journal of Practical Surgery ›› 2025, Vol. 45 ›› Issue (12) : 1422-1429.
PDF(3867 KB)
PDF(3867 KB)
Application of a deep-learning cascade model for near-infrared autofluorescence parathyroid identification
Objective To assess the effectiveness of a two-stage deep-learning near-infrared autofluorescence (NIRAF) model for improving intraoperative parathyroid identification accuracy and to validate its utility in reducing false-positive rates and providing anatomical localization reference. Methods A total of 101 patients undergoing thyroidectomy at Fujian Medical University Union Hospital from January 2023 to December 2023 were prospectively enrolled. Under standard operating-room lighting at a fixed distance of 15 cm, a 785-nm laser NIR camera was used to acquire NIRAF images from fresh specimens’ post-resection, yielding 30,122 frames to construct the “Niraf24” dataset. The model consisted of a YOLOv8x detection network for fluorescence-signal localization and a Segment Anything Model v2 (SAM2) segmentation network for thyroid contour segmentation and background restoration. Performance was evaluated using sensitivity, precision, F1-score, false-positive rate, and intersection over union (IoU), and compared with conventional direct fluorescence reading. Results The two-stage model markedly reduced false positives: frame-level from 37.7% to 13.2% and specimen-level from 38.8% to 6.7% (both P<0.001). Precision increased from 62.3% to 86.8%, F1-score improved from 0.734 to 0.846, while sensitivity was maintained at 82.8%. The SAM2-derived thyroid contours achieved a mean IoU of (0.985±0.012), indicating highly consistent anatomical localization. The model remained robust in high-noise settings (brown adipose tissue, thermal coagulation eschar, diffuse high-fluorescence background, surgical dye contamination), effectively suppressing difficult false-positive signals. Without compromising sensitivity, the two-stage cascade approach markedly reduced false positives and improved overall performance compared to conventional interpretation methods, validating the task suitability of the “detection-first, classification-second” strategy and its feasibility for intraoperative application. Conclusion The YOLOv8-SAM2-based two-stage deep-learning cascade significantly enhances the specificity of NIRAF without compromising sensitivity, generating real-time, anatomically referenced visual information to support parathyroid preservation. This approach establishes a reproducible performance benchmark and offers a new paradigm for multicenter clinical validation and intraoperative intelligent decision-making, with the potential to reduce inadvertent parathyroidectomy and postoperative hypocalcemia.
parathyroid gland / near-infrared autofluorescence / deep learning / thyroidectomy / surgical decision support / artificial intelligence
| [1] |
We aimed to establish an artificial intelligence (AI) model to identify parathyroid glands during endoscopic approaches and compare it with senior and junior surgeons' visual estimation.
|
| [2] |
Hypocalcemia is the most common complication following thyroidectomy in children. Guidelines to manage post-thyroidectomy hypocalcemia are available for adults, but not children. The objective of this review was to identify practices related to hypocalcemia prevention and management in pediatric patients.We identified studies examining the prevention and management of hypocalcemia in pediatric patients post-thyroidectomy within PubMed, EMBASE, Web of Science and Cochrane databases. Three independent reviewers screened citations and reviewed full-text papers.A total of 15 studies were included, representing 1552 patients. The overall study quality was weak with lack of randomization and inconsistent outcome reporting. The pooled incidence of hypocalcemia from the 15 studies was 35.5% for transient hypocalcemia and 4.2% for permanent hypocalcemia. All studies discussed post-operative hypocalcemia treatment, with most patients requiring admission for intra-venous calcium therapy. One study described a protocol discharging asymptomatic patients on calcitriol and calcium. Three studies discussed preoperative calcium supplementation in patients at risk of hypocalcemia. No studies examined routine use of calcium and/or vitamin D supplementation to prevent post-operative hypocalcemia.A significant number of children undergoing thyroidectomy develop hypocalcemia. Despite this high incidence, our systematic review demonstrates significant practice variation surrounding post-thyroidectomy hypocalcemia prevention and management in children.III (systematic review of studies of which some were case-control studies (III) and some were case series (IV)).Copyright © 2020 Elsevier Inc. All rights reserved.
|
| [3] |
|
| [4] |
田文, 王冰. 甲状腺癌根治术关键技术标准及评价[J]. 中国实用外科杂志, 2024, 44(1): 38-42. DOI: 10.19538/j.cjps.issn1005-2208.2024.01.04.
|
| [5] |
|
| [6] |
|
| [7] |
Hypocalcemia is the most common postoperative complication of total thyroidectomy. Near‐infrared autofluorescence (NIRAF) technology is a surgical adjunct that has been increasingly utilized with the aim of preventing postoperative hypocalcemia, but its clinical benefits have not yet been firmly established. The aim of this study was to assess the clinical benefit of utilizing NIRAF technology in patients undergoing total thyroidectomy.
|
| [8] |
|
| [9] |
|
| [10] |
The preservation of parathyroid glands is crucial in endoscopic thyroid surgery to prevent hypocalcemia and related complications. However, current methods for identifying and protecting these glands have limitations. We propose a novel technique that has the potential to improve the safety and efficacy of endoscopic thyroid surgery.
|
| [11] |
花苏榕, 廖泉. 甲状腺癌术后复发再手术中甲状旁腺和神经保护[J]. 中国实用外科杂志, 2021, 41(8): 871-874. DOI: 10.19538/j.cjps.issn1005-2208.2021.08.08.
|
| [12] |
|
| [13] |
The success of parathyroidectomy in primary hyperparathyroidism depends on the intraoperative differentiation of diseased from normal glands. Deep learning can potentially be applied to digitalize this subjective interpretation process that relies heavily on surgeon expertise. In this study, we aimed to investigate whether diseased vs normal parathyroid glands have different near-infrared autofluorescence (NIRAF) signatures and whether related deep learning models can predict normal vs diseased parathyroid glands based on intraoperative in vivo images.
|
| [14] |
|
| [15] |
Near‐infrared autofluorescence imaging (NIFI) can be used to identify parathyroid gland (PG) during surgery. The purpose of the study is to establish a new model, help surgeons better identify, and protect PGs.
|
| [16] |
Near-infrared autofluorescence (NIRAF) imaging is known to reduce the incidence of post-thyroidectomy hypocalcemia. However, there are no studies on how much NIRAF imaging affects the serum parathyroid hormone (PTH) level after surgery. We investigated the changes of the serum PTH level and ionized calcium (iCa.) in patients undergoing total thyroidectomy with central neck dissection (CND).This retrospective study with historical control enrolled 542 patients who underwent total thyroidectomy with CND. Patients were divided into two groups: the NIRAF group (261 patients) and the control group (281 patients). PTH and iCa. level were measured at the hospital stay, 1 month, 3 months, and 6 months after surgery. In addition, the number of identified parathyroid glands (PGs), auto-transplanted PGs, and the inadvertent resection rate of PGs were evaluated.The incidence of postoperative hypoparathyroidism (PTH < 15pg/mL) was significantly lower in the NIRAF group during the hospitalization (88 patients: 33.7% vs. 131 patients : 46.6%; p = 0.002) and at 1 month postoperatively (23 patients : 8.8% vs. 53 patients : 18.9%; p = 0.001). There was no difference in the permanent hypoparathyroidism rate (6 months after surgery) between the NIRAF group and the control group (4.2% vs. 4.6%; p = 0.816). There was no difference in the incidence of hypocalcemia (iCa. < 1.09mmol/L) (during hospitalization: 6.5% vs. 10.0%, 1 month : 2.3% vs. 2.5%, 3 months : 0.8% vs. 0.7%, 6 months after surgery; 1.1% vs. 1.1% ) between the two groups. The number of inadvertently resected PGs was significantly lower in the NIRAF group (18:6.9% vs. 36:12.8%; p = 0.021).These results suggest that NIRAF imaging may reduce temporary hypoparathyroidism and the risk of inadvertent resection of PGs in patients undergoing total thyroidectomy with CND.
|
| [17] |
|
| [18] |
|
| [19] |
陈志达, 郗洪庆, 刘培发, 等. 近红外自体荧光显像技术在甲状腺肿瘤手术中辅助识别甲状旁腺有效性分析[J]. 中国实用外科杂志, 2021, 41(8): 882-885. DOI: 10.19538/j.cjps.issn1005-2208.2021.08.11.
|
| [20] |
|
| [21] |
Identification and preservation of parathyroid glands (PGs) remain challenging despite advances in surgical techniques. Considerable morbidity and even mortality result from hypoparathyroidism caused by devascularization or inadvertent removal of PGs. Emerging imaging technologies hold promise to improve identification and preservation of PGs during thyroid surgery.
|
| [22] |
The use of Artificial intelligence (AI) in healthcare has grown exponentially with the promise of facilitating biomedical research and enhancing diagnosis, treatment, monitoring, disease prevention and healthcare delivery. We aim to examine the current state, limitations, and future directions of AI in thyroidology.AI has been explored in thyroidology since the 1990s, and currently, there is an increasing interest in applying AI to improve the care of patients with thyroid nodules, thyroid cancer, and functional or autoimmune thyroid disease. These applications aim to automate processes, improve the accuracy and consistency of diagnosis, personalize treatment, decrease the burden for healthcare professionals, improve access to specialized care in areas lacking expertise, deepen the understanding of subtle pathophysiologic patterns, and accelerate the learning curve of less experienced clinicians. There are promising results for many of these applications. Yet, most are in the validation or early clinical evaluation stages. Only a few are currently adopted for risk stratification of thyroid nodules by ultrasound and determination of the malignant nature of indeterminate thyroid nodules by molecular testing. Challenges of the currently available AI applications include the lack of prospective and multicenter validations and utility studies, small and low diversity of training datasets, differences in data sources, lack of explainability, unclear clinical impact, inadequate stakeholder engagement, and inability to use outside of the research setting which might limit the value of their future adoption.AI has the potential to improve many aspects of thyroidology; however, addressing the limitations affecting the suitability of AI interventions in thyroidology is a prerequisite to ensure AI provides added value for patients with thyroid disease.
|
/
| 〈 |
|
〉 |